Fair Value Measurements and Investments - Schedule of Reconciliation of Investments in Equity Securities (Detail) - Preferred Stock [Member] - Neo Medical [Member] - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of equity securities beginning balance	$ 4,951	$ 6,084
Conversion of loan into preferred equity securities	8,224
Unrealized loss recognized in other expense, net	(2,233)
Fair value of equity securities Ending balance	10,942	6,084
Cumulative unrealized gain (loss) on Neo Medical preferred equity securities	$ (2,953)	$ 413